A detailed history of Massmutual Trust CO Fsb transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 154 shares of DNLI stock, worth $4,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154
Previous 154 -0.0%
Holding current value
$4,863
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$14.96 - $23.22 $164 - $255
-11 Reduced 6.67%
154 $3,000
Q1 2024

Apr 09, 2024

BUY
$15.83 - $23.35 $759 - $1,120
48 Added 41.03%
165 $3,000
Q4 2023

Jan 03, 2024

BUY
$16.2 - $23.18 $1,360 - $1,947
84 Added 254.55%
117 $2,000
Q3 2023

Oct 03, 2023

BUY
$20.63 - $30.17 $226 - $331
11 Added 50.0%
33 $0
Q2 2023

Aug 01, 2023

BUY
$23.37 - $32.96 $514 - $725
22 New
22 $0
Q2 2022

Jul 07, 2022

SELL
$20.88 - $35.19 $542 - $914
-26 Closed
0 $0
Q1 2022

Apr 08, 2022

BUY
$29.0 - $47.27 $754 - $1,229
26 New
26 $1,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $4.24B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.